Results for tag: "Glyxambi"

Glyxambi is a medication used to treat type 2 diabetes. It is a combination of two drugs, empagliflozin and linagliptin, which work together to reduce blood sugar levels. It is used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes. Glyxambi is part of a class of drugs known as Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. These drugs can help to regulate blood sugar levels, reduce cholesterol, and treat other conditions such as obesity and thyroid disorders. The Glyxambi market is a rapidly growing segment of the Endocrine and Metabolic Disorders Drugs market. It is driven by the increasing prevalence of type 2 diabetes and the need for effective treatments. Companies in the Glyxambi market include Boehringer Ingelheim, Eli Lilly, Merck, Novo Nordisk, and Sanofi. Show Less Read more